323 related articles for article (PubMed ID: 18161990)
1. Phosphorylation of c-Abl by protein kinase Pak2 regulates differential binding of ABI2 and CRK.
Jung JH; Pendergast AM; Zipfel PA; Traugh JA
Biochemistry; 2008 Jan; 47(3):1094-104. PubMed ID: 18161990
[TBL] [Abstract][Full Text] [Related]
2. Transactivation of Abl by the Crk II adapter protein requires a PNAY sequence in the Crk C-terminal SH3 domain.
Reichman C; Singh K; Liu Y; Singh S; Li H; Fajardo JE; Fiser A; Birge RB
Oncogene; 2005 Dec; 24(55):8187-99. PubMed ID: 16158059
[TBL] [Abstract][Full Text] [Related]
3. Identification of B cell adaptor for PI3-kinase (BCAP) as an Abl interactor 1-regulated substrate of Abl kinases.
Maruoka M; Suzuki J; Kawata S; Yoshida K; Hirao N; Sato S; Goff SP; Takeya T; Tani K; Shishido T
FEBS Lett; 2005 Jun; 579(14):2986-90. PubMed ID: 15893754
[TBL] [Abstract][Full Text] [Related]
4. An intramolecular SH3-domain interaction regulates c-Abl activity.
Barilá D; Superti-Furga G
Nat Genet; 1998 Mar; 18(3):280-2. PubMed ID: 9500553
[TBL] [Abstract][Full Text] [Related]
5. Drosophila abelson interacting protein (dAbi) is a positive regulator of abelson tyrosine kinase activity.
Juang JL; Hoffmann FM
Oncogene; 1999 Sep; 18(37):5138-47. PubMed ID: 10498863
[TBL] [Abstract][Full Text] [Related]
6. Introduction of a loss-of-function point mutation from the SH3 region of the Caenorhabditis elegans sem-5 gene activates the transforming ability of c-abl in vivo and abolishes binding of proline-rich ligands in vitro.
Van Etten RA; Debnath J; Zhou H; Casasnovas JM
Oncogene; 1995 May; 10(10):1977-88. PubMed ID: 7539119
[TBL] [Abstract][Full Text] [Related]
7. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
Brasher BB; Roumiantsev S; Van Etten RA
Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
[TBL] [Abstract][Full Text] [Related]
8. Proapoptotic function of the nuclear Crk II adaptor protein.
Kar B; Reichman CT; Singh S; O'Connor JP; Birge RB
Biochemistry; 2007 Sep; 46(38):10828-40. PubMed ID: 17764157
[TBL] [Abstract][Full Text] [Related]
9. The C-terminal SH3 domain of the mouse c-Crk protein negatively regulates tyrosine-phosphorylation of Crk associated p130 in rat 3Y1 cells.
Ogawa S; Toyoshima H; Kozutsumi H; Hagiwara K; Sakai R; Tanaka T; Hirano N; Mano H; Yazaki Y; Hirai H
Oncogene; 1994 Jun; 9(6):1669-78. PubMed ID: 8183562
[TBL] [Abstract][Full Text] [Related]
10. An efficient method for protein phosphorylation using the artificially introduced of cognate-binding modules into kinases and substrates.
Kobashigawa Y; Naito M; Inagaki F
J Biotechnol; 2007 Sep; 131(4):458-65. PubMed ID: 17875337
[TBL] [Abstract][Full Text] [Related]
11. c-Abl-binding protein interacts with p21-activated kinase 2 (PAK-2) to regulate PDGF-induced membrane ruffles.
Machuy N; Campa F; Thieck O; Rudel T
J Mol Biol; 2007 Jul; 370(4):620-32. PubMed ID: 17543336
[TBL] [Abstract][Full Text] [Related]
12. Cytoplasmic c-Abl provides a molecular 'Rheostat' controlling carcinoma cell survival and invasion.
Kain KH; Gooch S; Klemke RL
Oncogene; 2003 Sep; 22(38):6071-80. PubMed ID: 12955086
[TBL] [Abstract][Full Text] [Related]
13. NESH (Abi-3) is present in the Abi/WAVE complex but does not promote c-Abl-mediated phosphorylation.
Hirao N; Sato S; Gotoh T; Maruoka M; Suzuki J; Matsuda S; Shishido T; Tani K
FEBS Lett; 2006 Nov; 580(27):6464-70. PubMed ID: 17101133
[TBL] [Abstract][Full Text] [Related]
14. The leukaemic oncoproteins Bcr-Abl and Tel-Abl (ETV6/Abl) have altered substrate preferences and activate similar intracellular signalling pathways.
Voss J; Posern G; Hannemann JR; Wiedemann LM; Turhan AG; Poirel H; Bernard OA; Adermann K; Kardinal C; Feller SM
Oncogene; 2000 Mar; 19(13):1684-90. PubMed ID: 10763825
[TBL] [Abstract][Full Text] [Related]
15. Identification and functional analysis of a new phosphorylation site (Y398) in the SH3 domain of Abi-1.
Sato M; Maruoka M; Yokota N; Kuwano M; Matsui A; Inada M; Ogawa T; Ishida-Kitagawa N; Takeya T
FEBS Lett; 2011 Mar; 585(6):834-40. PubMed ID: 21320496
[TBL] [Abstract][Full Text] [Related]
16. Modelling of the ABL and ARG proteins predicts two functionally critical regions that are natively unfolded.
Buffa P; Manzella L; Consoli ML; Messina A; Vigneri P
Proteins; 2007 Apr; 67(1):1-11. PubMed ID: 17211892
[TBL] [Abstract][Full Text] [Related]
17. Analysis of chimeric Gag-Arg/Abl molecules indicates a distinct negative regulatory role for the Arg C-terminal domain.
Mysliwiec T; Perego R; Kruh GD
Oncogene; 1996 Feb; 12(3):631-40. PubMed ID: 8637720
[TBL] [Abstract][Full Text] [Related]
18. Organization of the SH3-SH2 unit in active and inactive forms of the c-Abl tyrosine kinase.
Nagar B; Hantschel O; Seeliger M; Davies JM; Weis WI; Superti-Furga G; Kuriyan J
Mol Cell; 2006 Mar; 21(6):787-98. PubMed ID: 16543148
[TBL] [Abstract][Full Text] [Related]
19. Analysis of human c-Abl tyrosine kinase activity and regulation in S. pombe.
Walkenhorst J; Goga A; Witte ON; Superti-Furga G
Oncogene; 1996 Apr; 12(7):1513-20. PubMed ID: 8622867
[TBL] [Abstract][Full Text] [Related]
20. Detection of c-Abl kinase-promoted phosphorylation of Rad51 by specific antibodies reveals that Y54 phosphorylation is dependent on that of Y315.
Popova M; Shimizu H; Yamamoto K; Lebechec M; Takahashi M; Fleury F
FEBS Lett; 2009 Jun; 583(12):1867-72. PubMed ID: 19427856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
